Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)Skin and Connective Tissue Diseases, chronic cutaneous lupus erythematosus, connective tissue disorder, cutaneous lupus erythematosus, discoid lupus erythematosus, skin disorder, subacute cutaneous lupus erythematosusActive, not recruitingPhase 22026-08-28NCT06980805

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Immunovant Sciences GmbH8

86 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site Number - 1000AuroraUnited States1
Site Number - 1002HersheyUnited States1
Site Number - 1003Saint Clair ShoresUnited States1
Site Number - 1004Saint JosephUnited States1
Site Number - 1005FremontUnited States1
Site Number - 1006SmithfieldUnited States1
Site Number - 1007CharlotteUnited States1
Site Number - 1008DurhamUnited States1
Site Number - 1009BufordUnited States1
Site Number - 1010AnnistonUnited States1
Site Number - 1011Miami LakesUnited States1
Site Number - 1012IrvingUnited States1
Site Number - 1013TroyUnited States1
Site Number - 1014HialeahUnited States1
Site Number - 1015PhiladelphiaUnited States1
Site Number - 1017JacksonvilleUnited States1
Site Number - 1018Chula VistaUnited States1
Site Number - 1019Auburn HillsUnited States1
Site Number - 1020BirminghamUnited States1
Site Number - 1021FarmingtonUnited States1
Site Number - 1022Beverly HillsUnited States1
Site Number - 1023Los AngelesUnited States1
Site Number - 1024MiamiUnited States1
Site Number - 1025OrlandoUnited States1
Site Number - 1026St LouisUnited States1